Viewing nowTapaginseng 10 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.

MFDS item code 202300370 · Approved 2023.01.30 · Insurance code 645605790
Improvement of blood glucose control in type 2 diabetes mellitus; treatment of chronic heart failure and chronic kidney disease
This medicine is used to support dietary and exercise therapies for blood sugar control in patients with Type 2 diabetes. It can be used alone or effectively manage blood sugar levels when combined with other medications. Additionally, it helps reduce the risk of death due to cardiovascular disease and risks of hospitalization and emergency visits related to heart failure in patients with chronic heart failure. In patients with chronic kidney disease, it slows the deterioration of kidney function and reduces the risk of end-stage kidney disease and cardiovascular death. This medication can be used with standard therapies for cardiovascular or kidney disease to improve overall health. Therefore, it is useful in the treatment of patients with Type 2 diabetes, chronic heart failure, and chronic kidney disease.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience with antidiabetic drug therapy who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR below 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR below 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in specific patients. Patients who have had allergic reactions to the active ingredient or additives of this medication, those with Type 1 diabetes, patients with diabetic ketoacidosis, and patients on dialysis should not take this medication. Patients with reduced fluid volume or issues with kidney function should use this medication cautiously. This medication may lower blood pressure or cause changes in serum creatinine levels, which could stress the kidneys; therefore, kidney function and blood pressure should be carefully monitored before and during treatment. Taking this medication may increase the risk of genital infections or urinary tract infections. If infection symptoms appear, consult a healthcare professional immediately. When used with medications that have risks of hypoglycemia, care should be taken to prevent blood sugar levels from dropping too low, and adjustments to doses of other diabetes medications may be necessary. Pregnant or nursing women are advised not to use this medication, and it should be discontinued immediately if pregnancy is confirmed. Elderly patients have a higher risk of kidney function decline and fluid volume reduction, thus greater caution is required when taking this medication. If symptoms of fluid volume reduction or hypotension occur, immediate notification is necessary, and the medication may be temporarily halted if needed. This medication can cause serious metabolic disorders known as diabetic ketoacidosis; if related symptoms (nausea, vomiting, abdominal pain, breathing difficulties, etc.) occur, notify a healthcare professional immediately. Additionally, this medication does not significantly affect driving or operating machinery, but caution is advisable when taken with drugs that have hypoglycemia risk. Finally, this medication has not been proven safe and effective in children, so it should not be used in this population.
Vulvovaginitis, balanitis and related genital infections, urinary tract infection, fungal infection, perineal necrosis, hypoglycemia, reduced fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, early treatment renal creatinine clearance reduction, dyslipidemia, early treatment serum creatinine elevation, increased blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, biliary stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory disturbance, cerebral infarction, nerve compression, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, intragastric air retention, frequent bowel movements, gastroenteritis, colorectal polyp, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, bronchitis, herpes zoster, sinusitis, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial edema, facial pain, warmth, influenza-like illness, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, menstrual irregularities, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcer, hyperhidrosis eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, dry eye, eye pain, retinal disorders, decreased vision, blepharitis, cataract, conjunctival edema, allergic conjunctivitis, conjunctivitis, double vision, eyelid edema, keratitis, glaucoma, visual impairment, vitreous floaters, oropharyngeal pain, allergic rhinitis, asthma, voice disorders, epistaxis, sleep apnea syndrome, wheezing, atherosclerosis, flushing, peripheral coldness, varicose veins, vascular headache, orthostatic hypotension, atrial fibrillation, diastolic dysfunction, anxiety disorder, nocturia, auditory hallucinations, sleep disorders, insomnia, fatty liver, gallbladder polyp, vertigo, tinnitus, anal-genital warts, adenoma, neuroma, pituitary neoplasm of unspecified type, male hypogonadism, thyroid cyst, thyroid nodule, food allergy, polycythemia, dyspepsia, nausea, diarrhea, vomiting, urinary retention, abnormal urination, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, next day syndrome, headache, nasopharyngitis, upper respiratory tract infection, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, itching, arthralgia, palpitations
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it is important to store it in a tightly sealed container. Moreover, it should be kept at room temperature between 1 and 30 degrees Celsius to maintain efficacy and safety.
Yellow, round, double-convex, film-coated tablet in a diamond shape
2 blisters/box [(14 tablets/blister) × 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
DaeHwa Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.